primary antibody (cd86 Search Results


apc anti-mouse cd86 antibody  (Guangzhou JET Bio-Filtration)
94
Guangzhou JET Bio-Filtration apc anti-mouse cd86 antibody
Apc Anti Mouse Cd86 Antibody, supplied by Guangzhou JET Bio-Filtration, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/apc anti-mouse cd86 antibody/product/Guangzhou JET Bio-Filtration
Average 94 stars, based on 1 article reviews
apc anti-mouse cd86 antibody - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
cd86 polyclonal antibody  (Bioss)
95
Bioss cd86 polyclonal antibody
Cd86 Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd86 polyclonal antibody/product/Bioss
Average 95 stars, based on 1 article reviews
cd86 polyclonal antibody - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
cd86 primary antibody  (Yeasen Biotechnology)
90
Yeasen Biotechnology cd86 primary antibody
(A–B) DCFH-DA FC assay and statistics of intracellular ROS in the cardiomyocytes of treated HF rats. (C) ELISA results for ROS in the ECM. (D) Neutrophil percentage in routine blood tests in HF rats after treatment. (E–F) Distribution and statistics of <t>CD86</t> + cells in the heart tissue of HF rats after treatment. (G) Expression levels of TNF-α and IL-10 in cardiac tissues of HF rats after treatment. (H–I) Retention of BMSCs in the pericardium for 1–4 days and statistical analysis. Unless otherwise specified, the relative quantities in the above figures were calculated and statistically analyzed using normal rats as controls.
Cd86 Primary Antibody, supplied by Yeasen Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd86 primary antibody/product/Yeasen Biotechnology
Average 90 stars, based on 1 article reviews
cd86 primary antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cd86 (rabbit, 13395-1-ap)  (Sanying Ltd)
90
Sanying Ltd cd86 (rabbit, 13395-1-ap)
(A–B) DCFH-DA FC assay and statistics of intracellular ROS in the cardiomyocytes of treated HF rats. (C) ELISA results for ROS in the ECM. (D) Neutrophil percentage in routine blood tests in HF rats after treatment. (E–F) Distribution and statistics of <t>CD86</t> + cells in the heart tissue of HF rats after treatment. (G) Expression levels of TNF-α and IL-10 in cardiac tissues of HF rats after treatment. (H–I) Retention of BMSCs in the pericardium for 1–4 days and statistical analysis. Unless otherwise specified, the relative quantities in the above figures were calculated and statistically analyzed using normal rats as controls.
Cd86 (Rabbit, 13395 1 Ap), supplied by Sanying Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd86 (rabbit, 13395-1-ap)/product/Sanying Ltd
Average 90 stars, based on 1 article reviews
cd86 (rabbit, 13395-1-ap) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


(A–B) DCFH-DA FC assay and statistics of intracellular ROS in the cardiomyocytes of treated HF rats. (C) ELISA results for ROS in the ECM. (D) Neutrophil percentage in routine blood tests in HF rats after treatment. (E–F) Distribution and statistics of CD86 + cells in the heart tissue of HF rats after treatment. (G) Expression levels of TNF-α and IL-10 in cardiac tissues of HF rats after treatment. (H–I) Retention of BMSCs in the pericardium for 1–4 days and statistical analysis. Unless otherwise specified, the relative quantities in the above figures were calculated and statistically analyzed using normal rats as controls.

Journal: Bioactive Materials

Article Title: Monascus pigment-protected bone marrow-derived stem cells for heart failure treatment

doi: 10.1016/j.bioactmat.2024.08.038

Figure Lengend Snippet: (A–B) DCFH-DA FC assay and statistics of intracellular ROS in the cardiomyocytes of treated HF rats. (C) ELISA results for ROS in the ECM. (D) Neutrophil percentage in routine blood tests in HF rats after treatment. (E–F) Distribution and statistics of CD86 + cells in the heart tissue of HF rats after treatment. (G) Expression levels of TNF-α and IL-10 in cardiac tissues of HF rats after treatment. (H–I) Retention of BMSCs in the pericardium for 1–4 days and statistical analysis. Unless otherwise specified, the relative quantities in the above figures were calculated and statistically analyzed using normal rats as controls.

Article Snippet: The CD86 primary antibody or Annexin V-FITC (Yeasen, 40302ES50) was diluted according to the manufacturer's instructions and applied to the sections, followed by overnight incubation at 4 °C.

Techniques: Enzyme-linked Immunosorbent Assay, Expressing